Objective: make a review of the main neurological diseases associated with neuromuscular scoliosis and perioperative care during scoliosis correction surgeries. Method: Non-systematic review using a Google Scholar platform for articles with the descriptor "neuromuscular scoliosis" in the journal title. Results and Discussion: 46 articles in English and 3 articles in Portuguese were used for this review. Conclusion: Neuromuscular scoliosis has the fastest course of evolution, higher rates of disability and higher rates of complications in corrective surgery when compared to idiopathic scoliosis. The knowledge of neurological diseases more associated with neuromuscular scoliosis helps in its early detection and its long-term monitoring.I.

Introduction: The disease SARS-CoV-2, named COVID-19, was officially declared a pandemic by the World Health Organization on March 11 th , 2020. SARS-CoV-2 contains a single-stranded, positive-sense RNA genome surrounded by an extracellular membrane containing a series of spike glycoproteins resembling a crown. Neuropsychiatric manifestations are common during viral pandemics but are not effectively addressed. Case Report: We report the case of a man, 42 years old, who after the infection by SARS-COV2, presented dysnomy, cognitive easing and errors in motor processing. Results and Discussion: Studies have shown the neuroinvasive capability of SARS-COV2, resulting in neurological complications.Common neurological symptoms are headache, dizziness, anosmia, dysgeusia, mental confusion, and muscle weakening, progressing toward severe complications like cerebrovascular disease, seizures, muscle pain, and Guillain-Barre syndrome. The patient in the present case, about seven days after the initial infection, began to have difficulties in naming basic objects and "cognitive" slowness in the performance of basic and instrumental activities of daily life, especially those that required mutual tasks and that required concentration. Patients may be at higher risk of developing cognitive decline after overcoming the primary COVID-19 infection. Neuroinvasive capacities and neuroinflammatory events that may lead to the same short-and long-term neuropathologies that SARS-CoV had shown in human and animal models. The presence of dementia, minimal cognitive impairment and problems with motor planning and execution has been described. Conclusion: A structured prospective evaluation should analyze the likelihood, time course, and severity of cognitive impairment following the COVID-19 pandemic.

RESUMOObjetivo: Comparar o efeito da fadiga muscular inspiratória com o da fadiga muscular expiratória sobre a capacidade funcional em pacientes ambulatórios com insuficiência cardíaca sistólica. Método: Estudo randomizado, cruzado, controlado e duplo-cego, em seguimento ambulatorial especializado, no período de junho de 2014 a dezembro de 2015. Os indivíduos serão alocados no grupo que fará esforço muscular inspiratório e expiratório (GEMI e GEME) com 80% da pressão respiratória máxima, para indução à fadiga, ou 0%, placebo (três séries de 10 repetições). A ordem do esforço e carga serão randomizadas. Antes e após o esforço muscular respiratório, serão realizados lactatometria capilar e teste de caminhada de seis minutos.Resultados esperados: Treinamento mais específico para os músculos respiratórios pode melhorar a capacidade funcional e o prognóstico desses indivíduos.

No abstract

Introduction: The human disease associated with the new coronavirus, called COVID-19, was initially discovered in Wuhan, China. Although the existing literature on cognitive damage resulting from this injury is still very scarce, recent studies have shown dysfunction in the field of sustained attention, memory, verbal fluency and executive function, especially in patients with baseline neurocognitive fragility, such as Parkinson's disease (PD). These tend to have exacerbation of symptoms related to PD, in addition to strong psychological distress. Therefore, the aim of the present study is to report the case of a patient with PD and Dementia who evolved with cognitive decline during SARS-CoV-2 infection. Case Report: We present the case of a 63-year-old male patient with Parkinson's disease and dementia diagnosed 1 year before the condition, who presented significant cognitive decline during the SARS-CoV-2 infection. Discussion: The presentation of COVID-19 reported here consists of an atypical manifestation of the disease in a patient susceptible to cognitive damage due to the underlying dementia. It is believed that this pathology can cause patients with cognitive impairments that last from months to years after the infection, as observed in SARS-CoV and MERS-CoV infections. Conclusion: the effects of SARS-CoV-2 on cognitive function are gradually more apparent. Still, clinical trials in the short, medium and long term are essential to determine the main risk and vulnerability factors associated with cognitive impairment by